ID
27409
Description
Study ID: 103094 Clinical Study ID: ARI103094 Study Title: ARI103094-Follow-Up Study for REDUCE Study Subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00883909 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: dutasteride Trade Name: Zytefor,Zyfetor,Duagen,Avolve,Avodart,Avidart Study Indication: Neoplasms, Prostate
Keywords
Versions (2)
- 11/13/17 11/13/17 -
- 11/26/17 11/26/17 -
Copyright Holder
GlaxoSmithKline
Uploaded on
November 13, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Non-Surgical Intervention GSK study Prostatic neoplasms NCT00883909
Non-Surgical Intervention GSK study Prostatic neoplasms NCT00883909
Description
Non-Surgical Intervention for Prostate Cancer
Description
Non-Surgical Intervention
Description
Start Date of Non-Surgical Intervention
Data type
date
Description
End Date of Non-Surgical Intervention
Data type
date
Description
Drug therapy
Data type
text
Description
Drug therapy specification
Data type
text
Description
External Beam Radiation Therapy
Data type
text
Description
External Beam Radiation Therapy
Data type
text
Description
External Beam Radiation Therapy
Data type
text
Description
Other type of Non-Surgical Intervention
Data type
text
Description
Other Non-Surgical Intervention specification
Data type
text